Leerink raised the firm’s price target on Xoma (XOMA) to $50 from $45 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XOMA:
- XOMA Royalty Completes Generation Bio Acquisition and Merger
- XOMA Royalty Appoints New Chief Financial Officer
- Xoma announces CFO Burns to step down, Trigilio to succeed
- XOMA Highlights Royalty Growth Strategy in Updated Presentation
- H.C. Wainwright remains bullish on Xoma following creative Takeda deal